COMMENTS 0
Ausbiz interview with Dr Sean Hall about the future of Medlab
Date: 2020-12-02
Author:
Dr. Sean Hall
Ausbiz interviews the CEO of Medlab, Sean Hall on the 2nd December 2020 about the future of Medlab
Tell us what you think login to share your thoughts.
ABOUT THE AUTHOR
Chief Executive Officer
Dr. Sean Hall
Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.
Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.
MORE BY THIS AUTHOR
Switzer Investor Day
4th Small and Micro-Cap Virtual Investor Day 2nd December 2020
2020-12-02
Down-scheduling CBD from Schedule 4 to Schedule 3
The TGA’s interim decision to down schedule CBD means some business plans will need to change, but the whole industry stands to benefit.
2020-09-16
Virtual Symposium 2020
Welcome to Medlab Clinical’s first Virtual Symposium where we proudly showcase our scientific endeavours and research achievements. Topics will encompass our core research areas: the applications and distinctions of medicinal cannabis, the microbiome and its influences and the significance and evidence of delivery platforms. Showcasing professional speakers renowned in their respective fields, delegates will have the opportunity to interact live and ask questions at the conclusion of sessions, and thereafter access to session recordings and presentation notes. Attendance to the symposium is free, instead, we kindly encourage delegates to make a donation to the Children’s Cancer Institute to support our joint mission of curing childhood cancer.
2020-07-09